Thomas Wei

Dr. Wei is now a postdoctoral researcher in Stanford University School of Medicine. His research currently focuses on new drug discovery and cardiovascular disease modeling using human induced pluripotent stem cells (iPSC). He is the inventor of several International patents on new small molecule drugs. Dr. Wei was supported by Stanford SPARK Program and joined Biomedical-Innovation and Entrepreneurship training course in Australia, 2014. He is a licensed and registered pharmacist in Taiwan, who has solid backgrounds and professional experimental skills in pharmacy, pharmacology and new drug discovery. Dr. Wei has been a volunteer of CBA since 2017. He also served Public Relationship Officer and then Secretary for CBA in 2017.